Key result
COVID-19 pandemic linked to a ~110% increase in adult ADHD prevalence among U.S. workers.
Why the study?
To analyze the relationship between U.S. workers' reported ADHD symptomatology and the impact of pandemic conditions on symptomatic impairment and estimated Adult ADHD prevalence.
Did the COVID-19 pandemic increase reported ADHD symptomatology and the estimated prevalence of Adult ADHD among U.S. workers?
Cross-Sectional (n=921)
Did the COVID-19 pandemic increase reported ADHD symptomatology and the estimated prevalence of Adult ADHD among U.S. workers?
The COVID-19 pandemic was associated with a significant increase in self-reported ADHD impairment and estimated prevalence among U.S. workers, highlighting the need to support neurodiverse employees in new work environments.
Answers are grounded in this paper and cite their sources.
Pandemic linked to higher worker ADHD prevalence; hypothesis-generating and requires longitudinal studies before clinical adoption.
In this study; we analyzed the relationship between U.S. workers’ reported levels of ADHD symptomatology and the impact of pandemic conditions on symptomatic impairment and the estimated prevalence of Adult ADHD. We compared data from the Adult ADHD Self-Report Scale Screener (ASRS) collected during the pandemic with data from two pre-pandemic studies. Our findings indicate that during the pandemic; mean impairment scores on all six ASRS items increased; leading to a predicted rise in the Adult ADHD diagnosis rate to 9.26%; compared to the pre-pandemic estimate of 4.4%. These results suggest that more adults experienced significant ADHD-related challenges during the pandemic. As organizations continue to implement remote work and other pandemic-related changes; it is important to consider the unique difficulties that neurodiverse workers; particularly those with ADHD; may face in adapting to these new work environments.
No takes yet. Share an insight, caveat, or question.
Edwards et al. (2025) conducted a cross-sectional in Attention-Deficit/Hyperactivity Disorder (ADHD) (n=921). COVID-19 pandemic conditions vs. Pre-pandemic conditions was evaluated on Estimated population prevalence of adult ADHD. During the COVID-19 pandemic, the estimated prevalence of adult ADHD diagnosis among U.S. workers increased to 9.26% compared to a pre-pandemic estimate of 4.4%.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: